- 4.9Impact Factor
- 9.0CiteScore
- 18 daysTime to First Decision
Exosomes and Nanomedicine Targeting β-Amyloid-Induced Neurotoxicity in Alzheimer’s Disease
This special issue belongs to the section “Molecular Neurobiology“.
Special Issue Information
Dear Colleagues,
β-Amyloid (Aβ) oligomers are major drivers of early synaptic dysfunction and impaired plasticity, Ca2+ overload, oxidative and ER stress, mitochondrial failure, and neuroinflammation, ultimately accelerating neuronal loss and cognitive decline in Alzheimer’s disease. Metabolic regulation—particularly AMPK and PPAR signaling—can reshape bioenergetics, lipid metabolism, and inflammatory tone, offering draggable leverage points. However, effective and safe delivery across the blood–brain barrier remains a central bottleneck for translation.
This Special Issue aims to unify molecular and translational advances in exosomes/extracellular vesicles (EVs) and nanomedicine that can prevent, diagnose, or reverse Aβ-induced neurotoxicity. We welcome studies on EV biogenesis and therapeutic cargo, engineered exosomes, nanoparticle and hybrid EV–nano delivery systems, BBB-penetrant targeting strategies, stimulus-responsive release, imaging and theragnostic platforms, and rigorous efficacy and safety evaluation in 2D/3D neuronal cultures, brain organoids, and in vivo models.
Dr. Ming-Chang Chiang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- β-amyloid
- Alzheimer’s disease
- exosomes/EVs
- nanomedicine
- blood–brain barrier
- targeted delivery
- neuroinflammation
- mitochondrial dysfunction
- AMPK
- PPARs
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

